For decades, access to premium livestock export markets rested on a single question: is the exporting country, or a defined zone within it, free of the diseases the importer is worried about? For a great many producers, the honest answer is no, and will remain no for the foreseeable future.
Why geographic freedom is out of reach for many exporters
Achieving and holding recognised freedom from a transboundary disease requires sustained surveillance, movement control, and often physical separation of livestock populations. In settings with mobile pastoral herds, extensive borders, wildlife reservoirs and seasonal movement driven by rainfall, the cost is very high and the result is fragile — a single incursion can suspend a status that took years and considerable public expenditure to obtain.
The practical effect has been to exclude producers from export markets on the basis of geography rather than on the basis of whether their specific product presents a risk.
What commodity-based trade changes
Commodity-based trade reframes the question. Instead of asking where the animal came from, it asks whether the commodity — this consignment of deboned, matured beef, for example — can transmit the pathogen of concern, given how it was produced, processed and handled.
The reasoning is that risk is not solely a property of origin. It is a property of the product and of the sequence of steps applied to it. Where a defined combination of measures reliably reduces the probability of pathogen survival to an acceptable level, the consignment can be traded safely even from an area that is not free of the disease.
In practice this means demonstrating an integrated set of controls: sourcing from animals that meet defined criteria, inspection before and after slaughter, processing steps that inactivate or exclude the pathogen, and verification that the whole sequence was actually applied to that consignment. Each step reduces risk; the argument rests on their combination.
What it demands in return
Commodity-based trade is not a lower standard. It is a different, and in some respects more demanding, one — because the burden of proof moves from a national veterinary status to the individual consignment.
- Traceability. The importing authority must be able to establish where the animals came from and what happened to them. Without this, the entire argument collapses.
- Verified process control. Processing steps must be documented, monitored and auditable — not asserted.
- Credible official oversight. The veterinary authority must be capable of supervising and certifying the system, which means competent inspection, laboratory support and enforcement.
- Risk analysis capability. The exporting country needs to be able to construct and defend the technical argument to a sceptical counterpart.
- Bilateral agreement. The approach must be accepted by the importing authority. This is negotiated, and it takes time.
Where digital systems earn their cost
Traceability and certification are the practical bottleneck, and this is where digital infrastructure has changed what is feasible. Electronic identification and movement recording make consignment-level history retrievable rather than theoretical. Electronic certification allows an importing authority to verify a certificate against the issuing authority's own records instead of assessing a paper document that could have been altered anywhere along the chain.
These systems also produce a side benefit that is frequently worth more than the export access itself: the same data supports disease surveillance, outbreak tracing, and evidence about where interventions are actually working.
The failure mode is well known. Traceability systems are often procured as technology projects — hardware, software, a database — without the institutional arrangements that make the data trustworthy: registration processes, data governance, field-level incentives to record accurately, and enforcement when records are not kept. A traceability system nobody uses correctly is worse than none, because it produces confident-looking data that will not survive an audit.
A realistic assessment
Commodity-based trade is not a shortcut and it is not universally applicable — it works for some commodity and pathogen combinations and not others. But for exporters whose route to conventional disease-free status is blocked by geography, mobility and cost, it is one of the few credible paths to premium markets, and it rewards investment in exactly the systems that improve animal health governance anyway.